Gefitinib Tablets: Pioneering Targeted Cancer Therapy

[daisy_miller]

Gefitinib is a breakthrough targeted therapy used to treat non-small cell lung cancer (NSCLC) in patients with specific epidermal growth factor receptor (EGFR) mutations. As a tyrosine kinase inhibitor (TKI), it blocks EGFR activity, preventing cancer cells from growing and spreading. Its precision-targeted action makes it a preferred treatment for advanced lung cancer cases.

India is home to several reputed Gefitinib manufacturers, producing high-quality and cost-effective alternatives to branded versions. These manufacturers adhere to stringent regulatory standards, including WHO-GMP and USFDA certifications, ensuring the drug’s safety, efficacy, and affordability.

With increasing global demand, gefitinib manufacturers india play a critical role in making this life-saving drug more accessible to patients worldwide. By offering competitive pricing and maintaining strict quality controls, Indian pharmaceutical companies support better cancer care, providing a reliable supply of Gefitinib to healthcare providers and distributors globally.